Disease/Infection News

RSS

P681R spike mutation enhances replication efficiency of SARS-CoV-2 delta variant

A team of scientists from the University of Texas, USA, has recently revealed that the P681R spike mutation is responsible for increased infectivity of the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The P681R spike mutation increases the replication of the delta variant by increasing the dissociation of S1 and S2 subunits at the furin cleavage site. The study is currently available on the bioRxiv* preprint server.

18 Aug 2021

Naive B cells could be useful for predicting vaccination response in immunocompromised

A recent study conducted at the Medical University of Graz, Austria, has revealed that the number of naïve B cells in the blood could independently predict the magnitude of immune response induced by coronavirus disease 2019 (COVID-19) vaccines in immunocompromised patients. The study is currently available on the medRxiv* preprint server.

17 Aug 2021

Study reveals high racial disparity in stroke prevalence among COVID-19 patients

Black COVID-19 patients are more likely to have experienced strokes prior to their diagnosis than their non-Black counterparts, according to a study by Penn State College of Medicine researchers.

17 Aug 2021

Cote d’Ivoire launches Ebola vaccination of first responders and health workers

Cote d’Ivoire has launched Ebola vaccination of high-risk populations, including health workers and first responders in Abidjan, where an Ebola outbreak was declared on 14 August.

17 Aug 2021

Cote d’Ivoire declares the country’s first case of Ebola since 1994

The Ministry of Health of Cote d’Ivoire today confirmed the country’s first case of Ebola since 1994. This came after the Institut Pasteur in Cote d’Ivoire confirmed the Ebola Virus Disease in samples collected from a patient, who was hospitalized in the commercial capital of Abidjan, after arriving from Guinea.

17 Aug 2021

Partnering with faith-based community to increase COVID-19 vaccination rates among persons of color

Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation's most pressing healthcare challenges.

17 Aug 2021

COVIDome Explorer online portal launched to accelerate COVID-19 research on a global scale

To further accelerate COVID-19 research on a global scale, investigators from the University of Colorado Anschutz Medical Campus have created a multidimensional dataset, known as the COVIDome dataset, derived from hospitalized COVID-19 patients versus negative controls.

17 Aug 2021

Researchers receive $26.5 million NIH grant to pursue a new strategy for curing HIV

Over the last 40 years, HIV has shifted from a deadly and mysterious virus to one that can be controlled with daily drugs. But attempts to completely eliminate the virus from the bodies of people living with HIV, curing them for good, have failed.

17 Aug 2021

UC Davis Health offers third dose COVID-19 'booster' shots to immunocompromised patients

As COVID-19 cases rise due to the Delta variant, the Centers for Disease Control (CDC) has approved third dose vaccinations for patients whose immune systems are compromised moderately to severely.

17 Aug 2021

Study investigates airborne and fomite transmission of SARS-CoV-2 in Syrian hamsters

National Institutes of Health scientists studying SARS-CoV-2, the virus that causes COVID-19, have defined in Syrian hamsters how different routes of virus exposure are linked to disease severity.

17 Aug 2021

Weill Cornell Medicine receives $28.5 million Martin Delaney Collaboratory grant to lead HIV cure research

Weill Cornell Medicine has been awarded a five-year, $28.5 million Martin Delaney Collaboratory grant from the National Institutes of Health to lead a multi-institutional effort aimed at finding a cure for HIV.

17 Aug 2021

First-of-its-kind clinical trial network established in Asia to treat and prevent drug-resistant infections

Wellcome Trust has provided a grant of S$2.5 million to the National University of Singapore to establish the Asian Clinical Research Network to conduct antimicrobial clinical research to develop the most effective ways to treat and prevent life-threatening drug-resistant infections.

17 Aug 2021

UK delivers Oxford-AstraZeneca vaccine doses to Egypt

The package donated by the UK was shipped via COVAX, with the support of UNICEF and WHO, and arrived in Cairo yesterday (16 August).

17 Aug 2021

Lyme disease linked to increased risk of mental disorders, suicidality

In a new study, U.S. and Danish researchers report that patients who received a hospital diagnosis of Lyme disease—inpatient, outpatient, or at the ER—had a 28 percent higher rate of mental disorders and were twice as likely to have attempted suicide post-infection, compared to individuals without the diagnosis.

17 Aug 2021

New nanobiotechnology shows remarkable ability to battle dangerous fungal infections

They’re roughly the same size as a coronavirus particle, and 1000 times smaller than a human hair, yet newly engineered nanoparticles developed by scientists at the University of South Australia, are punching well above their weight when it comes to treating drug-resistant fungal infections.

17 Aug 2021

Disease/Infection News

P681R spike mutation enhances replication efficiency of SARS-CoV-2 delta variant

Naive B cells could be useful for predicting vaccination response in immunocompromised

Study reveals high racial disparity in stroke prevalence among COVID-19 patients

Cote d’Ivoire launches Ebola vaccination of first responders and health workers

Cote d’Ivoire declares the country’s first case of Ebola since 1994

Partnering with faith-based community to increase COVID-19 vaccination rates among persons of color

COVIDome Explorer online portal launched to accelerate COVID-19 research on a global scale

Researchers receive $26.5 million NIH grant to pursue a new strategy for curing HIV

UC Davis Health offers third dose COVID-19 'booster' shots to immunocompromised patients

Study investigates airborne and fomite transmission of SARS-CoV-2 in Syrian hamsters

Weill Cornell Medicine receives $28.5 million Martin Delaney Collaboratory grant to lead HIV cure research

First-of-its-kind clinical trial network established in Asia to treat and prevent drug-resistant infections

UK delivers Oxford-AstraZeneca vaccine doses to Egypt

Lyme disease linked to increased risk of mental disorders, suicidality

New nanobiotechnology shows remarkable ability to battle dangerous fungal infections

New rapid test for understanding immunity against COVID-19

Making the nanobody big again for Cryo-EM

In UK's 1st wave, 10% of COVID infections were acquired in hospitals

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

How delta and kappa variants of SARS-CoV-2 evade the immune system

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News